quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:00:53·1213d
NEWSRelease
Applied Molecular Transport Inc. logo
Gesher I Acquisition Corp. logo
Century Therapeutics Inc. logo
+1

Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022

AMTI· Applied Molecular Transport Inc.GIAC· Gesher I Acquisition Corp.IPSC· Century Therapeutics Inc.LEV· The Lion Electric Company
Health CareFinanceConsumer Discretionary
Original source

Companies

  • AMTI
    Applied Molecular Transport Inc.
    Health Care
  • GIAC
    Gesher I Acquisition Corp.
    Finance
  • IPSC
    Century Therapeutics Inc.
    Health Care
  • LEV
    The Lion Electric Company
    Consumer Discretionary

Recent analyst ratings

  • Feb 25IPSCUpdateTD Cowen-
  • Aug 12LEVUpdateDA Davidson$1.00
  • Aug 8IPSCUpdateRodman & Renshaw$6.00
  • Aug 28IPSCUpdateJP Morgan$5.00
  • Aug 4LEVUpdateNational Bank Financial$2.75
  • Mar 27LEVUpdateR. F. Lafferty$7.00

Related

  • SEC7d
    SEC Form PRE 14A filed by Century Therapeutics Inc.
  • INSIDER13d
    SEC Form 4 filed by Murphy Martin Patrick
  • INSIDER13d
    SEC Form 3 filed by new insider Murphy Martin Patrick
  • INSIDER20d
    SEC Form 4 filed by Cowan Chad
  • SEC28d
    Century Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC28d
    SEC Form 424B5 filed by Century Therapeutics Inc.
  • INSIDER38d
    SVP Finance & Operations Carr Douglas sold $17,953 worth of shares (7,043 units at $2.55), decreasing direct ownership by 1% to 507,261 units (SEC Form 4)
  • INSIDER38d
    Officer Russotti Gregory sold $25,684 worth of shares (10,076 units at $2.55), decreasing direct ownership by 2% to 515,427 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022